| n (%) | M | SD |
---|---|---|---|
Number of males | 12 (57.1) | Â | Â |
Number of females | 9 (42.9) | Â | Â |
Receiving stimulant medication | 10 (47.6) | Â | Â |
Age | 21 | 39.2 | 11.4 |
IQ | 21 | 120.1 | 10.1 |
Comorbidities | Â | Â | Â |
No other disorder | 8 (38.1) | Â | Â |
Major depressive disorder | 2 (9.5) | Â | Â |
Anxiety disorder | 11 (52.4) | Â | Â |
Other disorders | 7 (33.3) | Â | Â |
ASRS | |||
Pre | 21 | 44.4 | 8.8 |
Post | 20 | 41.2 | 9.1 |
Follow up | 20 | 39.3 | 11.2 |
ANT-r measures | 21 | Â | Â |
Flanker conflict | |||
Pre | Â | 175.4 | 160.7 |
Post | Â | 155.1 | 147.0 |
Follow up | Â | 150.0 | 143.6 |
Alerting | |||
Pre | Â | 41.9 | 175.5 |
Post | Â | 34.7 | 157.9 |
Follow up | Â | 35.0 | 144.6 |
Validity | |||
Pre | Â | 93.0 | 176.0 |
Post | Â | 104.4 | 162.6 |
Follow up | Â | 112.2 | 155.1 |